The SQUID Trial for the Embolization of the Middle Meningeal Artery for Treatment of Chronic Subdural Hematoma (STEM)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Adam Arthur, MD, MPH
Semmes-Murphy Neurologic and Spine Institute
Principal Investigator - David Fiorella, MD, PhD
Stony Brook University Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
32 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chu Cote de Nacre
Caen, France
- Chu Hopital Bicetre
Le Kremlin-Bicêtre, France
- Hopital Pitie Salpetriere
Paris, France
- Chu Hopital Maison Blanche
Reims, France
- Universitätsklinikum Heidelberg
Heidelberg, Germany
- Klinikum Nurnberg Sud
Nuremberg, Germany
- Gregorio Maranon Hospital
Madrid, Spain
- Barrow Neurological Institute
Phoenix, Arizona, United States
- Carondolet St. Joseph'S
Tucson, Arizona, United States
- Riverside Community Hospital
Riverside, California, United States
- Santa Barbara Cottage Hospital
Santa Barbara, California, United States
- Los Robles Hospital and Medical Center
Thousand Oaks, California, United States
- Swedish Medical Center
Englewood, Colorado, United States
- Baptist Health
Jacksonville, Florida, United States
- Emory University
Atlanta, Georgia, United States
- Wellstar Kennestone Hospital
Marietta, Georgia, United States
- University of Kansas
Kansas City, Kansas, United States
- Johns Hopkins Medicine
Baltimore, Maryland, United States
- Nebraska Health
Omaha, Nebraska, United States
- Overlook Medical Center
Summit, New Jersey, United States
- Nyu Langone Health
New York, New York, United States
- Stony Brook University
Stony Brook, New York, United States
- Montefiore Medical Center
The Bronx, New York, United States
- Geisinger Medical Center
Danville, Pennsylvania, United States
- Penn State Health Hershey Medical Center
Hershey, Pennsylvania, United States
- Thomas Jefferson University
Philadelphia, Pennsylvania, United States
- Rhode Island Hospital
Providence, Rhode Island, United States
- Baptist Memorial Hospital
Memphis, Tennessee, United States
- Methodist University Hospital
Memphis, Tennessee, United States
- University of Utah
Salt Lake City, Utah, United States
- Swedish Cherry Hill
Seattle, Washington, United States
- West Virginia University
Morgantown, West Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Nov 2020
- Primary completion
- 23 May 2024
- Completion
- 23 May 2024
- Last update posted
- 4 Jun 2026
- Registered enrollment
- 319
- Registry id
- NCT04410146
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.